Brain Metastases In ErbB2-Positive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: capecitabine|DRUG: topotecan|DRUG: lapatinib
Sponsor: GlaxoSmithKline